Human cytomegalovirus (HCMV), also known as human herpesvirus 5 (HHV-5), is a member of the Betaherpesvirus family (including HHV-6 and HHV-7). Cytomegalovirus (CMV) is a double-stranded DNA virus with the largest genome of any herpesvirus. The virus is transmitted horizontally through bodily secretions and can cross the placental barrier to facilitate vertical transmission (reviewed in reference 44). CMV results in a lifelong infection characterized by the establishment of latency in myeloid progenitor cells, followed by periodic reactivation. CMV elicits a strong cellular immune response, and the CMV-specific T cells of some individuals can account for greater than 10% of the total T-cell population (16, 22, 64) . In immunocompetent individuals, CMV infection is generally asymptomatic and controlled by the cell-mediated immune response; however, in immunocompromised individuals (i.e., neonates, transplant patients, and AIDS patients), it can cause severe diseases, such as congenital disorders, CMV retinitis, and a variety of opportunistic infections.
Human cytomegalovirus (HCMV), also known as human herpesvirus 5 (HHV-5), is a member of the Betaherpesvirus family (including HHV-6 and HHV-7). Cytomegalovirus (CMV) is a double-stranded DNA virus with the largest genome of any herpesvirus. The virus is transmitted horizontally through bodily secretions and can cross the placental barrier to facilitate vertical transmission (reviewed in reference 44) . CMV results in a lifelong infection characterized by the establishment of latency in myeloid progenitor cells, followed by periodic reactivation. CMV elicits a strong cellular immune response, and the CMV-specific T cells of some individuals can account for greater than 10% of the total T-cell population (16, 22, 64) . In immunocompetent individuals, CMV infection is generally asymptomatic and controlled by the cell-mediated immune response; however, in immunocompromised individuals (i.e., neonates, transplant patients, and AIDS patients), it can cause severe diseases, such as congenital disorders, CMV retinitis, and a variety of opportunistic infections.
Various lab-adapted and clinical strains of HCMV have been isolated and sequenced; most notable are AD169 (13) , Toledo (46) , Towne (17) , and Merlin (15) . Furthermore, there are a number of clinical strains that have been cloned as bacterial artificial chromosomes, such as TB40/E (62), TR, PH, and FIX (VR1814) (46) . The full-length genomes of CMVs from a number of different animal species, including mice (54), rats (68) , guinea pigs (33, 59) , and tree shrews (6) , have been isolated and sequenced. Given their high degree of genetic relatedness to humans, nonhuman primates (NHPs) likely represent the best animal model to study HCMV biology. A variety of CMVs from Old and New World primates have also been described (37) , including chimpanzee CMV (14, 63) , rhesus CMV strains 68.1 and 180.92 (28, 57) , cercopithecine herpesvirus 5 (CeHV-5) strains GR2715 and Colburn (accession no. FJ483968 and FJ483969, respectively), squirrel monkey CMV (SsciCMV-1; accession no. FJ483967), and owl monkey CMV (AtriCMV-1; accession no. FJ483970). CMVs are highly species-specific viruses (32, 44) and are consequently incapable of infecting even closely related species (A. P. N. Ambagala et al., unpublished data) . This specificity restricts the study of CMV to its target species and reiterates the importance of developing animal models that are closely related to humans in an effort to study HCMV pathogenesis.
Animal models to study CMV biology have been largely limited to mice, guinea pigs, and rhesus macaques. As an alternative, cynomolgus macaques (Macaca fascicularis) are a species of Old World monkeys that have the potential to serve as a novel NHP model to study CMV pathogenesis. Cynomolgus macaques are extensively used as an animal model for infectious disease research (12, 23, 36, 67) and transplant research (21, 34, 60) and are becoming an increasingly popular NHP model for human immunodeficiency virus (HIV) vaccine development (7, 47, 66) . Within the field of HIV vaccine design, there is a real need to diversify the pool of vectors undergoing testing. Recent studies using rhesus macaque CMV (RhCMV) as a simian immunodeficiency virus (SIV) vaccine vector have shown much promise in the ability of the vaccine to mount a robust effector memory response, thus providing vaccinated macaques with long-term protection from SIV disease progression (26, 29) . CMV strains are not conserved even between closely related NHPs, and our recent experience suggests that cynomolgus macaques are not readily infected with RhCMV (Ambagala et al., unpublished) . In order to overcome this strong host restriction and evaluate CMV as an HIV vector in a cynomolgus macaque-SIV model, we must use a cynomolgus macaque CMV (CyCMV). We have recently isolated and characterized a novel CyCMV (Ottawa strain) (3). Here we describe the complete genomic sequence and organization of the CyCMV genome for its use as an alternative NHP model to evaluate CMV pathogenesis and vaccine strategies. We compare and contrast the structural and functional genes of CyCMV with those of HCMV and RhCMV with respect to pathogenesis, immune evasion, and species specificity.
MATERIALS AND METHODS
CyCMV viral DNA isolation. Ottawa strain CyCMV was isolated from catheter-derived urine samples from a healthy, captive-bred, 4-year-old cynomolgus macaque of Philippine origin as described previously (3) . A cynomolgus macaque fibroblast cell line was not available at the time of isolation. Initial attempts were made to grow CyCMV in telomerase-immortalized rhesus macaque fibroblast cells (Telo-RF) (35) ; however, given the rapid growth properties of Telo-RF cells, this cell line could not support the slow growth kinetics of the CyCMV clinical isolate (3) . To circumvent this, we propagated the virus in human fetal lung fibroblast cells (MRC-5) (30) , which have slower growth properties and have been used extensively to propagate CMVs (9, 18, 63) . CyCMV was passaged 16 times in MRC-5 cells to obtain high-titer virus stocks. The virus was not plaque purified, and thus, the sequence likely represents a consensus of one or more strain variants. In order to isolate viral DNA, CyCMV-infected cells were lysed with Hirt extraction buffer (2ϫ Tris-EDTA, 1.2% SDS) for 20 min at room temperature, treated with 1 M sodium chloride overnight at 4°C, and subsequently centrifuged at 27,000 ϫ g for 35 min at 4°C to precipitate the cellular DNA and proteins. The supernatant containing viral DNA was treated with an RNase cocktail (60 g/ml RNase A and 160 U/ml RNase T1; Fermentas) for 2 h at 37°C and with pronase (1 mg/ml; Roche) for 2 h at 37°C. The supernatant was deproteinized with three phenol-chloroform extractions, and the viral DNA was precipitated with 0.3 M sodium acetate and 2 volumes of absolute ethanol overnight at Ϫ20°C. The sample was centrifuged at 17,000 ϫ g for 30 min at 4°C, and the viral DNA was overlaid on a discontinuous 5 to 20% sucrose gradient containing ethidium bromide (2 g/ml). Following centrifugation at 200,000 ϫ g for 2.5 h at 4°C, the viral DNA was visualized by UV illumination, collected and diluted in 1.5 volumes of water, and precipitated with 0.3 M sodium acetate and 2.5 volumes of absolute ethanol overnight at Ϫ20°C. The sample was centrifuged at 15,000 ϫ g for 30 min at 4°C and washed once with 70% ethanol, and the viral DNA was resuspended in water. CyCMV viral DNA (1 g) was digested with 20 U of HindIII or BamHI at 37°C overnight and fractionated by gel electrophoresis on a 0.8% agarose gel.
Next-generation DNA sequencing. Using 9.4 g of CyCMV DNA, a pairedend library with a 500-bp insert size was prepared to generate read lengths of 72 bp. To sequence the complete CyCMV genome, high-throughput Illumina Genome Analyzer II paired-end sequencing was performed at The Centre of Applied Genomics, Toronto, Ontario, Canada.
Bioinformatic assembly. The CyCMV genome was assembled de novo from 18,205,114 paired 72-bp reads (ϳ6,000-fold coverage) derived from a run of the Illumina Genome Analyzer II platform. Isolated paired ends were filtered to match the barcode (3,391,350 paired reads, ϳ1,120-fold coverage) and were assembled using Velvet (version 0.7.55) (73) . The best results were obtained using a kmer length of 39, the shortPaired mode, an insert length of 500 bp, and an expected coverage of 242 to yield a single large contig of 220 kbp.
Gap closing. The resulting Velvet assembly had 11 gaps (runs of Ns), with lengths of 9 to 124. We implemented a simple greedy assembly program that started from a seed sequence, identifying all possible overlapping reads and extended the seed until no further extension was possible. This process is analogous to those described previously (40, 72) . By providing the Velvet program with the areas close to gaps as seeds, we were able to generate sequence and close 10 of the 11 gaps in the initial Velvet assembly.
PCR sequencing. To confirm the integrity of the sequence, areas of low coverage from the next-generation sequencing data were verified by Sanger sequencing. PCR amplicons were gel purified with GeneClean II (MP Biomedicals) if necessary, cloned into the pCR-Blunt II-TOPO vector (Invitrogen), and transformed with chemically competent cells (Invitrogen). The full-length gene inserts were confirmed by Sanger sequencing using standard sequencing primers [M13 For (UP), 5Ј-CACGACGTTGTAAAACGAC-3Ј; M13 Rev (Ϫ27), 5Ј-CA GGAAACAGCTATGAC-3Ј (Invitrogen)]. Any remaining sequence was determined by primer walking. Sequences were aligned by ClustalW using Geneious Pro 5.1.7 (Biomatters Ltd., Auckland, New Zealand).
Error correction. In order to identify additional assembly errors, we aligned all of the Illumina reads with the finished assembly and corrected 64 positions (out of a total assembly size of 220 kbp) where the base pair present in the reference genome occurred 7 times less frequently than an alternative base and replaced each such base with the alternative. Furthermore, for regions of the assembly with low coverage or with conflicting base calls (including all 11 of the gaps initially identified as described above), we generated 71 Sanger sequences. By analyzing the Sanger sequences together with the base qualities in the aligned Illumina data, we were able to correct 24 additional assembly errors (14 single base pair modifications and 10 insertions/deletions of 1 to 23 bp). Finally, the CyCMV sequence was aligned with that of RhCMV 68.1 (accession no. AY186194) to confirm the orientation of the sequence.
ORF assignment. Open reading frames (ORFs) were identified on both strands with Geneious Pro 5.1.7 (Biomatters Ltd., Auckland, New Zealand) by using the following criteria: (i) the ORF began with a start codon (ATG) and ended with a stop codon, (ii) the ORF was a minimum of 100 amino acids (aa) long (including the start and stop codons), and (iii) the ORF did not overlap another ORF on the same strand within the same reading frame (13) . The majority (83%) of the genes were annotated by using these criteria, and the remaining genes were identified using a smaller size criterion of Ն30 aa in an effort to identify all possible ORFs. Homology for each ORF was determined using the BLASTP program (NCBI) with Ͼ20% identity. BLAST scores (2) and homology details were obtained from NCBI.
The genome homology of CyCMV with other CMVs was determined by Geneious alignment using a global alignment with free and end gaps and a cost matrix of 65% similarity (5.0/Ϫ4.0), a gap open penalty of 12, and a gap extension penalty of 3 (Geneious Pro 5.1.7; Biomatters Ltd., Auckland, New Zealand).
Nucleotide sequence accession number. The fully annotated and complete nucleotide sequence of the Ottawa strain of CyCMV has been submitted to GenBank and assigned accession number JN227533.
RESULTS
Genomic analysis of CyCMV. CyCMV was isolated from a cynomolgus macaque of Philippine origin and sequenced using paired-end sequencing (Illumina) to an average of 516-fold coverage/nucleotide. The CyCMV genome is 218,041 bp in length with a 49.5% GϩC content and 84% protein-coding density. CyCMV is shorter and less GC rich than HCMV AD169 (229,354 bp, 57.2%) (13) or chimpanzee CMV (CCMV) (241,087 bp, 61.7%) (14) and more comparable to both strains of RhCMV (68.1, 221,459 bp; 180.92, 215,678 bp, 49% GϩC content) (28, 57) (Fig. 1) Restriction digestion. To assess gross viral genome structure, a restriction digest analysis was performed and digested bands were confirmed based on predicted fragment sizes (Geneious Pro 5.1.7; Biomatters Ltd., Auckland, New Zealand). The CyCMV genome was digested with restriction enzymes HindIII and BamHI and fractionated on an agarose gel (Fig.  2a) . The digested CyCMV fragments were compared with the predicted fragments generated from the sequence data using bioinformatic software (Fig. 2b) . All fragments were present at the expected size, with the exception of an additional band running at approximately 2.7 kbp upon digestion with BamHI ( Fig. 2a) . It is possible that there is an extra BamHI site located between cy92 and cyUL69 that is not accurately represented in the final sequence data. This region encompasses the putative origin of lytic replication, a region known for structural complexity (10) . This region is inherently challenging to sequence due the presence of inverted and repeated sequence motifs (10) and proved difficult to sequence in our study by both next-generation and Sanger sequencing. The RhCMV genome does indeed contain a BamHI restriction site in the origin of lytic replication. We predict that the additional CyCMV band is the result of a missing restriction site in the sequence, although the restriction site may be present in the viral DNA. Gene assignment. We have identified 262 putative ORFs (Table 1 ) with a mean coding length of 789 bp. The genes were numbered starting at the left of the genome and continuing to the right with nomenclature similar to that used in annotating the ORFs in other NHP CMVs. The genomic organization of CyCMV is largely colinear with that of RhCMV. The CyCMV gene arrangement with color-coded herpesvirus core genes and gene families is shown in Fig. 3 . All alpha-, beta-, and gammaherpesviruses have 40 conserved genes known as core genes (44) . CyCMV contains 39 of the 40 core genes with no homologue to HCMV UL108. The function of UL108 is not known, and its deletion from the HCMV genome results in only moderate growth defects (17) .
Of the 262 CyCMV genes, 137 are homologous to HCMV genes, 243 are homologous to RhCMV 68.1 genes, and 200 are homologous to RhCMV 180.92 genes. With respect to the RhCMV genomes, CyCMV encodes homologues for 230 (89%) of the 260 RhCMV 68.1 genes and 180 (70%) of the 258 RhCMV 180.92 genes. CyCMV gene homologues were compared between HCMV and both strains of RhCMV based on their alignment bit scores to determine if a particular CyCMV gene is more closely related to a particular strain of CMV (Fig.  4) . The majority of the CyCMV genes are biased toward the RhCMV genomes; however, there are some exceptions in which the HCMV gene homologues have the higher bit scores. The outliers are mainly membrane proteins (MP) and tegument proteins (TP).
Genes missing from other macaque CMVs. In the 262 CyCMV ORFs, four genes show homology to HCMV genes that are not present in either strain of the RhCMV sequenced genomes (68.1 or 180.92). These genes include UL30, UL74A, UL126, and UL146. It should be noted that a wild-type isolate of RhCMV (RhCMV CNPRC ) does contain the HCMV homologue of UL146 (48) and cyUL146 has 76.1% identity with its RhCMV CNPRC counterpart. The functions of UL30 (cyUL30) and UL126 (cyUL126) have yet to be elucidated; however, it is known that UL74A (cyUL74A) encodes an envelope glycoprotein and UL146 (cyUL146) contains an alpha-chemokine homologue, vCXCL1, belonging to the UL146 gene family (50) . UL146 exhibits a high degree of sequence variability between HCMV strains and among species (5) . Notably, cyUL146 has retained the chemokine motif, ELRCXC (not shown), that is required for alpha-chemokines to recruit neutrophils (5). During CMV infection, vCXCL1 plays a role in neutrophil attraction and degranulation, resulting in increased viral dissemination both within and between hosts (50).
Tropism genes. CyCMV encodes a number of HCMV homologues for tropism genes that have been shown to be essential for HCMV propagation in various cell types. The HCMV homologues (UL128, UL130, and UL131A) that have been shown to be associated with endothelial cell, macrophage, and dendritic cell tropism (25, 61) have been retained in CyCMV. The CyCMV genes that show homology with the HCMV UL128-131 region include cyUL128 ex1 (37.1%) and ex2 (55.2%), cyUL130 (40.7%), and cyUL131A (35.3%). An additional HCMV gene known to be required for viral replication in human microvascular endothelial cells (HMVEC) is UL24 (17) , for which CyCMV encodes cyUL24 as a homologue with 53.3% identity. Similarly, HCMV UL64 and US29 were shown to be required for growth in human retinal pigment epithelial (RPE) cells (17) . CyCMV encodes a US29 homologue (cyUS29) with 38.1% identity but does not encode a UL64 homologue. Functional studies are required to determine if CyCMV can replicate in epithelial cells in the absence of a UL64 homologue. Furthermore, in the functional profiling of HCMV, it was determined that the deletion of UL10 and UL16 increases the viral titer in RPE cells and the deletion of US16 and US19 also results in a higher viral titers in HMVEC (17) . CyCMV does not encode the above-listed HCMV homologues, with the exception of cyUS19, which is an HCMV homologue of US19. With respect to RhCMV-specific tropism genes, four genes (Rh01, Rh159, Rh160, and Rh203) have been shown to be tropism determinants for RhCMV (strain 68.1) replication in rhesus RPE cells (38) . The CyCMV homologues of these RhCMV tropism genes include cyTRL1 (84.1%), cyUL148 (89%), cyUL132 (94.9%), and cyUS22 (96.9%). CyCMV deletion studies are required to determine if CyCMV exhibits the same impaired viral replication in epithelial cells. The CyCMV tropism genes (cyUL24, cyUL131A, cyUL148, and cyUS22) encode full-length homologues of their respective HCMV and/or RhCMV counterparts. However, the homologues for cyTRL1, cyUL128 ex1/ex2, cyUL130, cyUL132, cyUS19, and cyUS29 represent only partial alignments with the intact CyCMV ORF due to N-and/or C-terminal truncations.
Functional genes. Although CyCMV has homology with a number of HCMV MP and TP, the genes that have a functional role in DNA replication, packaging, and egress are the most conserved. These proteins include DNA-packaging terminase components (cyUL89 ex1, 84.8%; cyUL89 ex2, 86.5%; cyUL56, 73.2%), a DNA-packaging protein (cyUL51, 83.1%), nuclear egress membrane and lamina proteins (cyUL50, 80.6%; cyUL53, 75.4%), a major capsid protein (cyUL86, 76%), a single-stranded DNA-binding protein (cyUL57, 74.8%), capsid triplex subunits 1 and 2 (cyUL46, 72.1%; cyUL85, 74%), a DNA polymerase processivity factor (cyUL44, 69.2%), a uracil-DNA glycosylase (cyUL114, 69%), DNA helicase primase subunits (cyUL70, 65.3%; cyUL102, 67%; cyUL105, 71.9%), a capsid portal protein (cyUL104, 68.3%), a viral serine-threonine protein kinase (cyUL97, 66.5%), a DNase (cyUL98, 66%), a DNA polymerase (cyUL54, 62.2%), a small capsid protein (cyUL48a, 65.3%), a portal-capping/DNA-packaging protein (cyUL77, 64.5%), and ribonucleotide reductase subunit 1 (cyUL45, 61.2%). The percent identities to HCMV genes are described, and it should be noted that the RhCMV complements for these same genes are even more conserved, with an average of 99% identity to their CyCMV counterparts. Surface glycoproteins. CMV surface glycoproteins are commonly used for identification and classification purposes and to assess phylogenetic relationships between CMVs (3). CyCMV encodes HCMV homologues for glycoproteins B (cyUL55), N (cyUL73), O (cyUL74), H (cyUL75), M (cyUL100), and L (cyUL115). Glycoprotein N (UL73) is a highly variable HCMV glycoprotein (51); however, its CyCMV homologue (cyUL73) exhibits the highest degree of homology (60.8%) compared to the remaining HCMV glycoprotein homologues. Another highly polymorphic HCMV glycoprotein is glycoprotein O (UL74) (51), which is the least conserved of the glycoprotein homologues in CyCMV, with 43.7% identity.
Viral homologues of chemokine receptor and GPCR proteins. Chemokine receptor (CXCL) and G protein-coupled receptor (GPCR) gene homologues are carried by CMVs from various species. These receptor homologues are organized in gene clusters, and the number of repeated genes in a cluster differs between species and between isolates, given that these genes are dispensable for growth in fibroblast cells (1) . CyCMV has retained six alpha-chemokine receptor homologues that are clustered together in a 3.98-kbp coding region encompassing cyUL147 to cy184. Likewise, CyCMV contains a cluster of five GPCR homologues (cyUS28a, cyUS28b, cyUS28c, cyUS28d, and cyUS28e) that encode the HCMV homologue of US28, a GPCR known to bind chemokines (69) . CyCMV encodes seven genes (cyUL33 ex2, cyUL78, and cyUS28a to cyUS28e) that are homologous to three of the four GPCR family genes (UL33, UL78, and US28). The only GPCR homologue absent from the CyCMV genome is US27, a virion envelope glycoprotein (44) .
Immunomodulatory genes. CMVs contain a number of genes that function to evade the immune response of the infected host. CyCMV encodes HCMV homologues for major histocompatibility complex class I (MHC-I) downregulation genes (US2, US3, and US11), viral interleukin-10 (UL111.5A), a tumor necrosis factor receptor homologue (UL144), and antiapoptotic genes (UL36, UL37 ex1, and UL38). In addition to the HCMV genes, cy203 carries a homologue of the RhCMV-specific gene (rh178) involved in MHC-I downregulation by interference with the translation of the heavy chain portion of the MHC-I molecule (53, 56) . Although it was originally thought to be unique to RhCMV (53), it appears that this immunomodulatory gene may in fact be an NHP-specific immunevasin.
The HCMV immunomodulatory genes ␤2.7, UL16, UL18, UL142, US6, US8, and US10 are not present in CyCMV. Although these genes are important for evading the immune system, their deletion does not have any effect on viral growth in vitro (17, 42) . According to the criterion (Ͼ20% identity) used to assign CyCMV homologues, CyCMV does not contain a homologue of the HCMV US6 gene. The RhCMV gene Rh185 has a low degree of sequence homology with US6; however, it has been shown to be functionally similar to US6 and therefore has been assigned as a putative homologue (49) . Given that cy216 shows significant homology with Rh185 (95.3%) from the RhCMV 68.1 genome, we propose that this CyCMV gene may also function to downregulate MHC-I and may be considered a US6 homologue. We have previously shown that CyCMV downregulates MHC-I expression on the surface of CyCMV-infected cells (3) . Further functional studies are needed to determine if CyCMV has equivalent or uncharacterized homologues of the missing immunomodulatory genes to evaluate the effects of these deletions on immunomodulation. Antiapoptotic genes. The antiapoptotic genes carried by HCMV include a 2.7-kbp viral RNA (␤2.7) and the UL36 to UL38 genes (41) . It is likely that CyCMV does not transcribe a ␤2.7 gene equivalent, given than CyCMV does not encode an HCMV homologue of the predicted ORF (RL4) from which the ␤2.7 transcript is derived (42) . The absence of the ␤2.7 gene does not affect HCMV growth kinetics in vitro (42) . CyCMV contains homologues for the UL36 to UL38 genes (cyUL36 ex1 and ex2, cyUL37 ex1, and cyUL38, respectively). The function of UL36 is to inhibit caspase-8-induced apoptosis (vICA), and cyUL36 ex1 and ex2 have 44% and 58.4% identity with UL36. Similarly, UL37 is a mitochondrial inhibitor of apoptosis (vMIA) and cyUL37 ex1 has 30.5% identity with this HCMV gene. Human CMV UL38 (54.7% identity to cyUL38) is an antiapoptotic gene that blocks the cellular response pathway induced by stress, thus preventing cellular apoptosis; alternatively, when it is deleted from the genome, the target cells undergo apoptosis and HCMV exhibits viral replication defects (45, 65) . It remains to be determined if these CyCMV genes have the same antiapoptotic roles as their HCMV homologues.
Latency genes. Of the known CMV latency transcripts, CyCMV encodes only an HCMV homologue of UL111.5A (cyUL111.5A). The second exon of cy148 (cyUL111.5A ex2) has 37% identity with the latency-associated UL111.5A HCMV gene that encodes the viral interleukin-10 protein.
Like HCMV, cy148 carries a spliced transcript with 3 exons, which is analogous to UL111.5A during productive infection (31) and differs from the RhCMV 180.92 homologue (RhUL111a), which contains 4 exons (57). Comparable to RhCMV, CyCMV does not contain an HCMV homologue of UL81 and thus does not contain the UL81-82 antisense transcript (LUNA) that is involved in latency (8, 55) . Although CyCMV has retained a number of gene homologues from the HCMV ULbЈ region, it is missing the HCMV homologue of UL138, a known latency gene that is also absent from the RhCMV genomes. Substitution studies have shown that removing UL138 from HCMV does not affect the in vitro growth kinetics of the virus when propagated in fibroblast cells, although they suggest that it could be cell type specific (24) .
Spliced transcripts. CyCMV encodes at least eight genes that are the products of spliced mRNA transcripts, and these include the commonly spliced CMV genes. The spliced transcripts that have two exons include a virion envelope protein/ GPCR family protein (cy52 ex1 and cyUL33 ex2), tegument protein vICA (cyUL36), immediate-early glycoprotein vMIA (cyUL37), a DNA-packaging terminase component (cyUL89), an early phosphoprotein (cyUL112), IgG Fc-binding glycoprotein (cyUL119 ex1 and cy57 ex2), and a putative CC chemokine (cyUL128). Furthermore, cy148 contains 3 exons (cy148 ex1, cyUL111.5A ex2, and cy148 ex3) to produce the viral interleukin-10 protein. The cy161 ORF is spliced into 4 exons, where cyUL122 ex1 and cyUL123 ex2 produce immediateearly proteins 2 and 1, respectively, and cy161 ex3 and cy161 ex4 encode immediate-early proteins.
Missing genes. Similar to HCMV, CyCMV does not contain the RhCMV-specific viral homologue of cyclooxygenase-2 (COX-2) (28). CyCMV lacks an approximately 6.7-kbp coding region equivalent to that of RhCMV rh9 to rh16, which encompasses the COX-2 gene homologue of rh10. In comparison to HCMV, CyCMV is lacking full complements for 84 HCMV genes, although the vast majority of these genes are uncharacterized and their deletion from the HCMV genome does not affect viral growth kinetics (Table 2) . At the left terminus of the genome, CyCMV is lacking all of the RL genes except TRL1 and RL11 (cyTRL1 and cyRL11, respectively). These genes are generally present only in clinical isolates of CMV, as they are dispensable for growth in vitro (17) . The RL11 family of genes is not present in mouse or rat CMV (54, 68) . Of the absent HCMV genes, the only ones that have been reported to be required for viral replication are UL60 and UL90, both of which encode functionally uncharacterized proteins. It appears that CyCMV is lacking the HCMV homologues (UL58 to UL68) spanning the origin of lytic replication (oriLyt) that resides between cy92 and cyUL69. These HCMV genes (UL58 to UL68) are present in the AD169 strain; however, they are not present in the Toledo strain of HCMV or in either of the RhCMV strains. The only Rh-CMV homologues missing from the oriLyt area are rh94 and rh96, suggesting that CyCMV is not lacking any crucial genes in this region and has a gene allocation similar to that of HCMV (Toledo) and RhCMV.
Furthermore, CyCMV is also lacking complements of the UL2, UL12, UL65, UL108, and UL129 genes, all of which do not have a known function, with the exception of UL2 (putative MP). Only a modest effect on viral replication has been observed when these genes are deleted from the HCMV genome (17) . There is ambiguity in the literature regarding the effect of knocking out the MP UL124 (17) . The remaining HCMV gene deletions have yet to be examined for their effects on viral growth kinetics.
Phylogenetic analysis. Phylogenetic trees have been generated to depict the evolutionary relatedness of genes common to different CMVs (Fig. 5) . Genes that had the greatest number of sequenced strains were included in this analysis. As expected, these genes uniformly group more closely with RhCMV than with the other CMV strains. The cy216 gene was included in this analysis to clarify the discrepancy regarding the HCMV US6 homologue. For this gene, the number of substitutions per site for the branches separating CyCMV and RhCMV from HCMV is relatively high (0.994) in comparison to those of other genes represented by the phylogenetic trees. Furthermore of interest is the cy216 gene, in which the CyCMV complement is more closely related to RhCMV 68.1 than is RhCMV 180.92. (44) . c ND, not determined; Ϫ, no effect on viral replication; ϩ, modest effect on viral replication; ϩϩ, critical effect on viral replication; ϩϩϩ, required for viral replication.
d Effects of deletion differ between studies (17).
DISCUSSION
The newly characterized CyCMV (Ottawa strain) is 218,041 bp in length, encodes 262 ORFs, and is most closely related to the two published genomes of RhCMV (strains 68.1 and 180.92). Although we have predicted 262 ORFs, we acknowledge that this may not be a complete representation of the CyCMV genome and that there may be additional ORFs carried in the genome that have yet to be elucidated. The virus was not plaque purified, and thus, the sequence likely represents a consensus of one or more strain variants. Our particular Illumina sequencing run had a calculated error frequency of 1% and acted as a baseline for substitution frequencies. In this manner, we determined that sequence calls other than the consensus represent, on average, only 1.9%. This determination does not allow us to calculate how many deviances from the consensus are contained simultaneously in a single genome sequence but does suggest that our current sequence likely represents a mixed population with only a diminutive portion of variants. With respect to interhost variability, we have previously examined the amino acid sequence of glycoprotein B (cyUL55) and have observed 99% identity between animals from the same geographic origin (3) .
As the Ottawa strain of CyCMV is a multiply tissue culturepassaged virus, in vitro passage may have resulted in deletions impairing its coding capacity. However, in comparison to the multiple passages required to generate HCMV strains AD169 (54 passages) (19) and Towne (125 passages) (52), CyCMV (16 passages) would be considered only a moderately passaged isolate. Potential gene deletions could be further investigated by sequencing and characterizing a different isolate of CyCMV, specifically, a low-passage strain. The CyCMV genome is unique in that it contains four HCMV homologues (UL30, UL74A, UL126, and UL146) that are not present in either of the published RhCMV genomes (68.1 or 180.92), although an HCMV homologue of UL146 is present in a wild-type strain of RhCMV (RhCMV CNPRC ) (48) . There is no putative function for UL30 and UL126; however, it is known that UL74A is an envelope glycoprotein and UL146 is an alpha-chemokine homologue (vCXCL1). It has been suggested that vCXCL1 may act as a virulence determinant of CMV disease in individuals with a compromised adaptive immune system (43) . Although CyCMV is a multipassaged derivative, with respect to the chemokine and GPCR gene clusters, CyCMV resembles a minimally passaged virus in that it has retained the clusters of six alpha-chemokine receptor homologues and five GPCR homologues. The wild-type isolates of RhCMV contain six CXCL and five GPCR gene clusters; however, in annotated RhCMV strains 68.1 and 180.92, half or all of the CXCL genes are deleted while all of the GPCR genes in the clusters are retained (1). CyCMV does not appear to have lost these genes in the same way that the RhCMV genomes have.
CyCMV does not contain a viral COX-2 gene that appears to be unique to RhCMV (28) . Cellular COX-2 expression is induced upon HCMV infection and has been shown to play an important role in HCMV replication (74) . Unlike HCMV infection, RhCMV infection does not induce cellular COX-2 Given the importance of cynomolgus macaques as a widely utilized animal model for infectious disease and transplant research, the isolation and characterization of this highly prevalent endogenous virus may have a variety of applications. The seroprevalence of CyCMV in the cynomolgus macaque colony at the Public Health Agency of Canada in Ottawa, Ontario, is estimated to be 100% as measured by a CyCMV-specific enzyme-linked immunosorbent assay (3) . In other studies, it has been observed that greater than 95% of NHPs bred in captivity are CMV seropositive (4). Fortunately, it has been shown that CMV-seropositive rhesus macaques can be superinfected with RhCMV (27) . This has yet to be examined in cynomolgus macaques, although we believe that, as with RhCMV and HCMV, it would be possible achieve superinfection with CyCMV.
CMVs have evolved with their hosts over millions of years and have contained CMV-specific genes that are related to each host species. We have preliminary data suggesting that it may be inherently difficult to cross the species-specific barrier and infect cynomolgus macaques with RhCMV (Ambagala et al., unpublished). Although the CyCMV genome is nearly 90% identical to that of RhCMV (at the nucleotide level) and the genes are largely colinear with those of RhCMV, clearly there are factors influencing the host range specificity of the virus. The mechanism by which a host cell restricts viral replication from a different species has not been well elucidated. However, it is known that this restriction does not occur exclusively during the entry phase of CMV infection, as it has been shown that CMV has the capacity to infect a host cell from a distant species (20) . One possible mechanism by which the host cell inhibits CMV replication from other species may be mediated by apoptosis, suggesting that the foreign virus cannot overcome the cellular innate immune defense of the host (32) . CMVs contain antiapoptotic genes (␤2.7, UL36, UL37 ex1, and UL38) that function to overcome the apoptosis response induced by the host innate immune response following CMV infection (44) . The HCMV homologues of the UL36 to UL38 antiapoptotic genes are encoded by the CyCMV genome (cyUL36 ex1 and ex2, cyUL37 ex1, and cyUL38), and these CyCMV genes show high homology (ϳ96 to 97% identity) with their RhCMV counterparts ( Table 1) . Although it has been suggested that these antiapoptotic genes are important for host restriction in vivo, this does not appear to be the situation in vitro, where the species specificity is less restricted. CyCMV productively infects and replicates in human (MRC-5), rhesus macaque (Telo-RF), and cynomolgus macaque (MSFT) fibroblast cell lines (unpublished data). It is known that when CMV strains are grown in fibroblast cell lines, they classically eliminate the tropism genes required for replication in different cell types, most notably, endothelial cells (71) . Although CyCMV has been propagated in fibroblast cells prior to sequencing, the genes that are required for endothelial cell tropism (UL128, UL130, and UL131A) have been retained in CyCMV (cyUL128 ex1/ex2, cyUL130, and cyUL131A, respectively). Furthermore, we have preliminary evidence demonstrating that CyCMV infects and efficiently replicates in human umbilical vein endothelial cells (data not shown). Endothelial cell tropism plays an important role in natural infection and viral transmission (70) ; thus, CyCMV may have utility for examining viral dissemination and pathogenesis in endothelial cells.
Congenital CMV remains the most common viral cause of birth defects in newborns, and yet there is still no vaccine (11) . The burden of CMV disease is apparent not only in children but also in adults, specifically, those receiving solid organ or bone marrow transplants and those suffering from an immunocompromising disease such as HIV/AIDS. We have reason to be hopeful regarding the ability to make a CMV vaccine, given the success attained with another herpesvirus, varicellazoster virus, in which the licensed vaccine has been highly effective in reducing the mortality associated with varicella infections in the United States (39) . We hope this newly sequenced and characterized CyCMV genome will provide the necessary groundwork for further studies evaluating the utility of cynomolgus macaques as an alternative NHP model in which to study CMV biology, pathogenesis, and vaccine design.
